Similar to reports in breast cancer cells, we observed leptin-induced expression of EMT genes and stemness markers in CICs isolated from ovarian cancer (CD44+), supporting its role in the maintenance of a more aggressive phenotype [49]. This evidence concerns the gene CD44 and ovarian cancer.